2025
SJR Q1
JCR Q2 · 4,2
8 eşleşen makale
SCIE
Dergi ayrıntısı
Drugs and Aging
- Ülke
- Switzerland · Western Europe
- Tür
- journal
- ISSN
-
1170229X11791969
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 1,354
- Quartile Q1
- H-Index 119
- Atıf/yayın 4,5
- Doküman (3y) 244
- Atıf (3y) 1.166
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 4,2
- 5Y JIF 4
- JCI 0,81
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Geriatrics and Gerontology Q1
- Pharmacology (medical) Q1
Alanlar
- Medicine
WoS kategorileri
- Geriatrics & Gerontology | Pharmacology & Pharmacy
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,354 | 4,2 | 4 | 0,81 | Q2 | 119 |
| 2024 | Q1 | Q2 | 1,252 | 3,8 | 3,5 | 0,78 | Q2 | 114 |
| 2023 | Q1 | Q2 | 0,894 | 3,4 | 3,5 | 0,74 | Q2 | 114 |
| 2022 | Q1 | Q3 | 0,865 | 2,8 | 3,4 | 0,68 | Q2 | 114 |
| 2021 | Q1 | Q2 | 1,048 | 4,3 | 4,1 | 0,76 | Q2 | 114 |
| 2020 | Q2 | Q2 | 1,024 | 3,9 | 3,7 | 0,74 | Q2 | 114 |
| 2019 | Q2 | Q2 | 0,912 | 2,8 | 2,9 | 0,72 | Q2 | 114 |
| 2018 | — | Q2 | — | 2,8 | 3,2 | 0,74 | Q2 | — |
| 2017 | Q1 | Q3 | 1,072 | 2,4 | 3 | 0,77 | Q2 | 114 |
| 2016 | Q1 | Q2 | 1,263 | 2,8 | 3,1 | — | — | 114 |
| 2015 | Q1 | Q2 | 1,389 | 2,6 | 2,8 | — | — | 114 |
| 2014 | Q1 | Q2 | 1,33 | 2,8 | 3 | — | — | 114 |
| 2013 | Q1 | Q2 | 0,98 | 2,5 | 2,7 | — | — | 114 |
| 2012 | Q1 | Q2 | 0,975 | 2,6 | 2,7 | — | — | 114 |
| 2011 | Q1 | Q2 | 0,919 | 2,7 | 2,3 | — | — | 114 |
| 2010 | Q1 | Q2 | 1,1 | 2,7 | 2,5 | — | — | 114 |
| 2009 | — | Q2 | — | 2,2 | 2,3 | — | — | — |
| 2008 | — | Q2 | — | 2,1 | 2,5 | — | — | — |
| 2007 | — | Q2 | — | 2,1 | 2,3 | — | — | — |
| 2006 | — | Q2 | — | 2,2 | — | — | — | — |
| 2005 | — | Q2 | — | 2,1 | — | — | — | — |
| 2004 | — | Q2 | — | 2 | — | — | — | — |
| 2003 | — | Q1 | — | 2,8 | — | — | — | — |
| 2002 | — | Q2 | — | 2,2 | — | — | — | — |
| 2001 | — | Q2 | — | 1,9 | — | — | — | — |
| 2000 | — | Q1 | — | 2,3 | — | — | — | — |
| 1999 | — | Q1 | — | 2,1 | — | — | — | — |
| 1998 | — | Q1 | — | 1,6 | — | — | — | — |
| 1997 | — | Q2 | — | 1,2 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | Q2 | 27/72 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 102/356 |
| 2024 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | Q3 | 22/73 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 92/352 |
| 2023 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | Q3 | 32/74 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 105/354 |
| 2022 | GERIATRICS & GERONTOLOGY | SCIE | Q3 | Q3 | 36/54 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 171/278 |
| 2021 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | Q3 | 25/54 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 105/279 |
| 2020 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | Q3 | 24/53 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 114/276 |
| 2019 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | Q3 | 24/51 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 125/271 |
| 2018 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | Q3 | 26/53 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 114/267 |
| 2017 | GERIATRICS & GERONTOLOGY | SCIE | Q3 | Q3 | 31/53 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 138/261 |
| 2016 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | — | 22/49 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 106/257 |
| 2015 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | — | 22/49 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 99/255 |
| 2014 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | — | 24/50 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 93/255 |
| 2013 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | — | 23/49 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 114/256 |
| 2012 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | — | 23/47 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 101/261 |
| 2011 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | — | 18/45 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 98/261 |
| 2010 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | — | 15/45 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 98/252 |
| 2009 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | — | 16/40 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 125/237 |
| 2008 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | — | 17/36 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 122/219 |
| 2007 | GERIATRICS & GERONTOLOGY | SCIE | Q3 | — | 16/31 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 100/205 |
| 2006 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | — | 12/30 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 92/199 |
| 2005 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | — | 13/29 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 83/193 |
| 2004 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | — | 10/29 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 77/187 |
| 2003 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | — | 8/27 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 45/185 |
| 2002 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | — | 9/27 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 56/188 |
| 2001 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | — | 8/24 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 59/186 |
| 2000 | GERIATRICS & GERONTOLOGY | SCIE | Q1 | — | 5/22 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 41/181 |
| 1999 | GERIATRICS & GERONTOLOGY | SCIE | Q1 | — | 4/22 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 42/175 |
| 1998 | GERIATRICS & GERONTOLOGY | SCIE | Q1 | — | 5/22 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 58/178 |
| 1997 | GERIATRICS & GERONTOLOGY | SCIE | Q2 | — | 10/22 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 75/157 |